Insulated glass unit with sealant composition having reduced permeability to gas

Details for Australian Patent Application No. 2007209944 (hide)

Owner Momentive Performance Materials Inc.

Inventors Landon, Shayne J.

Agent Fisher Adams Kelly

Pub. Number AU-A-2007209944

PCT Pub. Number WO2007/089698

Priority 11/345,463 01.02.06 US

Filing date 30 January 2007

Wipo publication date 9 August 2007

International Classifications

C03C 27/06 (2006.01) Joining glass to glass or to other materials - Joining glass to glass by processes other than fusing

C03C 27/10 (2006.01) Joining glass to glass or to other materials - with the aid of adhesive specially adapted for that purpose

C08G 18/10 (2006.01) Polymeric products of isocyanates or isothiocyanates

C08G 18/28 (2006.01) Polymeric products of isocyanates or isothiocyanates

C08G 18/71 (2006.01) Polymeric products of isocyanates or isothiocyanates

C09J 175/04 (2006.01) Adhesives based on polyureas or polyurethanes - Polyurethanes

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/089698 Priority application(s): WO2007/089698

13 January 2011 Section 223 Application Allowed

  Momentive Performance Materials Inc. The time in which to request examination has been extended to 08 Jan 2011. Address for service in Australia - Fisher Adams Kelly Level 29 12 Creek Street Brisbane QLD 4000 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007209945-Sealant composition having reduced permeability to gas

2007209928-4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK2 modulators and pharmaceutical compositions containing them